Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...

In a landmark achievement for both Uganda and the global medical community, the United States Patent and Trademark Office ...

Terrain Biosciences launches from stealth today as the world's first RNA design-build company, using advanced AI and its ...

We recently compiled a list of the These 10 Firms Were Last Week’s Worst Performers. In this article, we are going to take a ...

Young, a music teacher, met the King at UCLH last year while taking part in the first personalised trial of the mRNA vaccine for melanoma - the most dangerous form of skin cancer. He had invited the ...

We recently compiled a list of the 12 Best Healthcare Stocks to Buy According to Analysts. In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against the other ...

On Friday, February 7, a hearing took place in the Montana state legislature on a bill that would ban the use of mRNA ...

A New Hope? Russia has developed a therapeutic cancer vaccine, which means it won’t prevent cancer but aims to cure it.

However, analysts project potential upside of 92% in 2025, according to the Street-high estimate.  Investors should also note that Merck pays a dividend yielding 3.71%, more than twice the healthcare ...

Left to right - Dr. Riccardo Rampado & Prof. Dan Peer. Researchers at Tel Aviv University have achieved a breakthrough in ...

To come up with last week’s worst performers, we considered only the stocks with at least $2 billion in market capitalization ...

mRNA vaccines, pivotal in the fight against COVID-19, are now emerging as a promising innovation in cancer treatment. As clinical trials advance, Ben Hargreaves finds the technology is poised to ...